OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023
Thomas P. Burris, Ian Mitchelle S. de Vera, Isabelle Côté, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1233-1318
Open Access | Times Cited: 20

Showing 20 citing articles:

Activation of Genes by Nuclear Receptor/Specificity Protein (Sp) Interactions in Cancer
Stephen Safe, Evan Farkas, Amanuel Hailemariam, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 284-284
Open Access | Times Cited: 1

Central role of SUMOylation in the regulation of chromatin interactions and transcriptional outputs of the androgen receptor in prostate cancer cells
Kaisa‐Mari Launonen, Vera Varis, Niina Aaltonen, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 16, pp. 9519-9535
Open Access | Times Cited: 5

EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells
Jasmin Huttunen, Niina Aaltonen, Laura Helminen, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4

The cyclin‐dependent kinase inhibitor AT7519 is a human RORγt agonist
Kaja Karaś, Joanna Pastwińska, Anna Sałkowska, et al.
Immunology and Cell Biology (2025)
Closed Access

Biased signaling in drug discovery and precision medicine
Ren-Lei Ji, Ya‐Xiong Tao
Pharmacology & Therapeutics (2025), pp. 108804-108804
Closed Access

Adropin: A Cardio-Metabolic Hormone in the Periphery, a Neurohormone in the Brain?
Andrew A. Butler, Peter J. Havel
Peptides (2025), pp. 171391-171391
Closed Access

The Role of ESS2/DGCR14: Is It an Essential Factor in Splicing and Transcription?
Ichiro Takada, Shinya Hidano, Tohru Nakagawa, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4056-4056
Open Access

RORγT agonists as immune modulators in anticancer therapy.
Joanna Pastwińska, Iwona Karwaciak, Kaja Karaś, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189021-189021
Open Access | Times Cited: 4

Structural Perspective of NR4A Nuclear Receptor Family and Their Potential Endogenous Ligands
Ryoichi Hashida, Takeshi Kawabata
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 3, pp. 580-590
Open Access | Times Cited: 1

Mechanism of antagonist ligand binding to REV-ERBα
Mohammad Homaidur Rahman, Lamees Hegazy
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Nuclear Receptors: Mechanistic Insights into Endocrine Resistance in Prostate and Breast Cancers
Macrina B. Silva-Cázares, Stephanie I. Núñez-Olvera, Ricardo Hernández-Barrientos, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 444-456
Open Access | Times Cited: 1

How to Make Glucocorticoids Safer
Thomas P. Burris
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 388, Iss. 3, pp. 748-750
Open Access

Investigating REV-ERBβ Binding Pocket Dynamics with Implications for Rational Design of Small Molecule Modulators
Shriyansh Srivastava, Rakesh Thakur, Abhinav Vishnu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Modeling Stress-Related Hormones and Delayed Anxiety
Kairo Alan Albernaz-Mariano, Vitor A. L. Juliano, Érica de Almeida Duque, et al.
Springer eBooks (2024), pp. 1-27
Closed Access

Agonists of the nuclear receptor PPARγ can produce biased signaling
Mariah Rayl, Michelle D. Nemetchek, Andrew A. Voss, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 6, pp. 309-318
Open Access

Leveraging nuclear receptor mediated transcriptional signaling for drug discovery: Historical insights and current advances
Riya Ben Patel, Surbhi Kumari Barnwal, Arabi Mohammed Saleh M A, et al.
Advances in protein chemistry and structural biology (2024), pp. 191-269
Closed Access

Evaluation of N-palmitoylethanolamine (PEA) binding to nuclear receptors through docking and molecular dynamics studies
Fakher Frikha, Sami Aifa
Computers in Biology and Medicine (2024) Vol. 184, pp. 109421-109421
Closed Access

Nuclear receptor profiling for subtype classification and as prognostic markers in 33 cancer types
Kazuya Nakamichi, Hironori Suzuki, Yusuke Yamamoto, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access

Page 1

Scroll to top